CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Tiamulin

泰妙菌素 杂质对照品Tiamulin Impurities

EP22 个杂质条目22 impurity entries

本页汇总 泰妙菌素 的 22 个杂质对照品条目,其中药典杂质标注了 EP/USP 编号。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 22 impurity reference standards of Tiamulin with EP/USP numbering where applicable. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 泰妙菌素(Tiamulin)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 分析方法Analytical MethodsDevelopment and validation of an LC-MS/MS method for the quantification of tiamulin, trimethoprim, tylosin, sulfadiazine and sulfamethazine in medicated feed
    Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment · 2018 · Patyra E et al.  ·  PMID 29324179  ·  DOI
  2. 分析方法Analytical MethodsQuantification of 8-α-hydroxy-mutilin as marker residue for tiamulin in rabbit tissues by high-performance liquid chromatography-mass spectrometry
    Analytical and bioanalytical chemistry · 2015 · De Baere S et al.  ·  PMID 25592328  ·  DOI
  3. 分析方法Analytical MethodsDetermination of Tiamulin Concentration in Sow Milk and in Sera of Suckling Piglets
    Molecules (Basel, Switzerland) · 2023 · Cybulski P et al.  ·  PMID 37836783  ·  DOI
  4. 分析方法Analytical MethodsDetermination of antibiotics such as macrolides, ionophores and tiamulin in liquid manure by HPLC-MS/MS
    Analytical and bioanalytical chemistry · 2003 · Schlüsener MP et al.  ·  PMID 12707765  ·  DOI
  5. 分析方法Analytical MethodsTiamulin hydrogen fumarate--veterinary uses and HPLC method of determination in premixes and medicated feeding stuffs
    Acta poloniae pharmaceutica · 2010 · Krasucka D et al.  ·  PMID 21229887

泰妙菌素 —— 原料药与杂质对照品Tiamulin — drug substance & impurities

共 23 个条目(含原料药本体)23 items incl. the drug substance
Tiamulin structure
EP原料药 APIAPI
泰妙菌素Tiamulin
Tiamulin
CAS No.55297-95-5
Chemical FormulaC28H47NO4S
Purity>95%询价On request
10mg25mg50mg100mg
Tiamulin Impurity 1 (Tiamulin EP Impurity A) (Mutilin) structure
EPA
泰妙菌素杂质1 (泰妙菌素EP杂质A) (姆替林)Tiamulin Impurity 1 (Tiamulin EP Impurity A) (Mutilin)
Tiamulin Impurity 1 (Tiamulin EP Impurity A) (Mutilin)
CAS No.6040-37-5
Chemical FormulaC20H32O3
Purity>95%询价On request
10mg25mg50mg100mg
Tiamulin Impurity 2 (Tiamulin EP Impurity B) structure
EPB
泰妙菌素杂质2(泰妙菌素EP杂质B)Tiamulin Impurity 2 (Tiamulin EP Impurity B)
Tiamulin Impurity 2 (Tiamulin EP Impurity B)
CAS No.7708-55-6
Chemical FormulaC13H21NS
Purity>95%询价On request
10mg25mg50mg100mg
Tiamulin Impurity 3 (Tiamulin EP Impurity C) structure
EPC
泰妙菌素杂质3(泰妙菌素EP杂质C)Tiamulin Impurity 3 (Tiamulin EP Impurity C)
Tiamulin Impurity 3 (Tiamulin EP Impurity C)
CAS No.589-32-2
Chemical FormulaC12H28N2S2
Purity>95%询价On request
10mg25mg50mg100mg
Tiamulin Impurity 5 (Tiamulin EP Impurity E) structure
EPE
泰妙菌素杂质5(泰妙菌素EP杂质E)Tiamulin Impurity 5 (Tiamulin EP Impurity E)
Tiamulin Impurity 5 (Tiamulin EP Impurity E)
CAS No.113323-39-0
Chemical FormulaC28H45NO4S
Purity>95%询价On request
10mg25mg50mg100mg
Tiamulin Impurity 7 (Tiamulin EP Impurity G) structure
EPG
泰妙菌素杂质7(泰妙菌素EP杂质G)Tiamulin Impurity 7 (Tiamulin EP Impurity G)
Tiamulin Impurity 7 (Tiamulin EP Impurity G)
CAS No.125-65-5
Chemical FormulaC22H34O5
Purity>95%询价On request
10mg25mg50mg100mg
Tiamulin Impurity 10 (Tiamulin EP Impurity J) structure
EPJ
泰妙菌素杂质10(泰妙菌素EP杂质J)Tiamulin Impurity 10 (Tiamulin EP Impurity J)
Tiamulin Impurity 10 (Tiamulin EP Impurity J)
CAS No.31771-36-5
Chemical FormulaC22H34O4
Purity>95%询价On request
10mg25mg50mg100mg
Tiamulin Impurity 11 (Tiamulin EP Impurity K) structure
EPK
泰妙菌素杂质11(泰妙菌素EP杂质K)Tiamulin Impurity 11 (Tiamulin EP Impurity K)
Tiamulin Impurity 11 (Tiamulin EP Impurity K)
CAS No.31716-11-7
Chemical FormulaC22H34O4
Purity>95%询价On request
10mg25mg50mg100mg
Tiamulin Impurity 12 (Tiamulin EP Impurity L) structure
EPL
泰妙菌素杂质12(泰妙菌素EP杂质L)Tiamulin Impurity 12 (Tiamulin EP Impurity L)
Tiamulin Impurity 12 (Tiamulin EP Impurity L)
CAS No.31716-01-5
Chemical FormulaC29H40O7S
Purity>95%询价On request
10mg25mg50mg100mg
Tiamulin Impurity 13 (Tiamulin EP Impurity M) structure
EPM
泰妙菌素杂质13 (泰妙菌素EP杂质M)Tiamulin Impurity 13 (Tiamulin EP Impurity M)
Tiamulin Impurity 13 (Tiamulin EP Impurity M)
CAS No.14431-61-9
Chemical FormulaC24H36O5
Purity>95%询价On request
10mg25mg50mg100mg
Tiamulin EP Impurity O structure
EPO
硫姆林EP杂质OTiamulin EP Impurity O
Tiamulin EP Impurity O
CAS No.100-38-9
Chemical FormulaC6H15NS
Purity>95%现货In stock
10mg25mg50mg100mg
Tiamulin Impurity 16 (Tiamulin EP Impurity P) structure
EPP
泰妙菌素杂质16(泰妙菌素EP杂质P)Tiamulin Impurity 16 (Tiamulin EP Impurity P)
Tiamulin Impurity 16 (Tiamulin EP Impurity P)
CAS No.848129-54-4
Chemical FormulaC28H38O7S
Purity>95%询价On request
10mg25mg50mg100mg
Tiamulin Impurity 18 Chloride (Tiamulin EP Impurity R Chloride) structure
EPR
泰妙菌素杂质18 氯化物 (泰妙菌素EP杂质R 氯化物)Tiamulin Impurity 18 Chloride (Tiamulin EP Impurity R Chloride)
Tiamulin Impurity 18 Chloride (Tiamulin EP Impurity R Chloride)
CAS No.23616-79-7
Chemical FormulaC19H34N+·Cl-
Purity>95%询价On request
10mg25mg50mg100mg
Tiamulin Impurity 18 Bromide (Tiamulin EP Impurity R Bromide) structure
EPR
泰妙菌素杂质18 溴化物 (泰妙菌素EP杂质R 溴化物)Tiamulin Impurity 18 Bromide (Tiamulin EP Impurity R Bromide)
Tiamulin Impurity 18 Bromide (Tiamulin EP Impurity R Bromide)
CAS No.25316-59-0
Chemical FormulaC19H34N+·Br-
Purity>95%询价On request
10mg25mg50mg100mg
Tiamulin Impurity 18 (Tiamulin EP Impurity R) structure
EPR
泰妙菌素杂质18 (泰妙菌素EP杂质R)Tiamulin Impurity 18 (Tiamulin EP Impurity R)
Tiamulin Impurity 18 (Tiamulin EP Impurity R)
CAS No.54225-72-8
Chemical FormulaC19H34N+
Purity>95%询价On request
10mg25mg50mg100mg
Tiamulin Impurity 19 structure
19
泰妙菌素杂质19Tiamulin Impurity 19
Tiamulin Impurity 19
CAS No.442681-88-1
Chemical FormulaC20H32O4
Purity>95%询价On request
10mg25mg50mg100mg
Tiamulin Impurity 20 structure
20
泰妙菌素杂质20Tiamulin Impurity 20
Tiamulin Impurity 20
CAS No.409326-94-9
Chemical FormulaC13H28N2OS2
Purity>95%询价On request
10mg25mg50mg100mg
Tiamulin Impurity 20  Dihydrochloride structure
20
泰妙菌素杂质20 双盐酸盐Tiamulin Impurity 20 Dihydrochloride
Tiamulin Impurity 20 Dihydrochloride
CAS No.96776-36-2
Chemical FormulaC13H28N2OS2·2HCl
Purity>95%询价On request
10mg25mg50mg100mg
Tiamulin Impurity 21 structure
21
泰妙菌素杂质21Tiamulin Impurity 21
Tiamulin Impurity 21
CAS No.965-32-2
Chemical FormulaC19H34N+·Cl-
Purity>95%询价On request
10mg25mg50mg100mg
Tiamulin Impurity 22 structure
22
泰妙菌素杂质22Tiamulin Impurity 22
Tiamulin Impurity 22
CAS No.87680-55-5
Chemical FormulaC20H32O3
Purity>95%询价On request
10mg25mg50mg100mg
Tiamulin Impurity 23 structure
23
泰妙菌素杂质23Tiamulin Impurity 23
Tiamulin Impurity 23
CAS No.1648609-73-7
Chemical FormulaC20H30O2
Purity>95%询价On request
10mg25mg50mg100mg
Tiamulin Impurity 28 (8-α-Hydroxy Mutilin) structure
28
泰妙菌素杂质28 (8-α-羟基截短侧耳素)Tiamulin Impurity 28 (8-α-Hydroxy Mutilin)
Tiamulin Impurity 28 (8-α-Hydroxy Mutilin)
CAS No.443150-08-1
Chemical FormulaC20H32O4
Purity>95%询价On request
10mg25mg50mg100mg
Tiamulin Impurity 21-d7 structure
21-D7
泰妙菌素杂质21-d7Tiamulin Impurity 21-d7
Tiamulin Impurity 21-d7
CAS No.1998128-81-6
Chemical FormulaC19H27D7N+·Cl-
Purity>95%询价On request

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

泰妙菌素 —— 研究文献与合成路线Tiamulin — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 泰妙菌素 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Tiamulin. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Isolation of a novel Sphingomonas strain able to degrade the pleuromutilin tiamulin: omic analysis reveals its transformation pathway
    Perruchon C, Tagkalidou N, Kalogiouri N, et al. · 2024
  2. Development and validation of an optical SPR biosensor assay for tiamulin in grass and groundwater
    Wilson S, Fodey TL, Traynor I, et al. · Food and agricultural immunology · 2007

合成与制备工艺专利Synthesis & process patents

  1. Tiamulin fumarate for veterinary use, lung-targeting microsphere of tiamulin fumarate salt and preparation method thereof
    LING TIAN, LAN LIU, YUN MO, LIU JUN, et al. · 公开号 CN101543475CN101543475 · 2009
  2. Method for preparing raw material of pleuromutilin for use in tiamulin synthesizing process
    HAN QINGENG SHEN · 公开号 CN1775755CN1775755 · 2006
  3. Method for preparing raw material containing pleuromutilin for tiamulin production process
    HAN QINGENG SHEN · 公开号 CN1814765CN1814765 · 2006
  4. Method for preparing colon targeted pill of tiamulin used for poultry and livestock
    LI XUDONG BAO · 公开号 CN1969837CN1969837 · 2007
  5. Solid dispersion containing fumaric acid tiamulin and its preparation method
    SHEN DETANG CHU · 公开号 CN1768736CN1768736 · 2006

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

泰妙菌素 杂质谱研究要点Tiamulin — impurity profiling notes

下面这些是拿到 泰妙菌素 的 23 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 23 impurity entries for Tiamulin, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

本品种含药典编号杂质(EP/USP)。申报时药典已收载的杂质通常需要逐项对照,建议优先备齐药典编号对照品,再补充工艺与降解杂质。This drug substance includes pharmacopoeially designated impurities (EP/USP). Monographed impurities normally need item-by-item comparison during filing, so secure the pharmacopoeial standards first, then fill in process and degradation impurities.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances